Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 3/20 | 0.41 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.35 |
| ▸ | TUBB | P07437 | 2/20 | 0.35 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.35 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.35 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.35 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.35 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.35 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.35 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.35 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.35 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.35 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.35 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6908039 | 0.77 | SLC2A1 (0.41) | MCHR1SLC2A1MEN1KMT2APDE3B | |
| SCHEMBL6605280 | 0.75 | SLC2A1 (0.50) | MCHR1SLC2A1MEN1KMT2APDE3B | |
| SCHEMBL6621452 | 0.75 | SLC2A1 (0.39) | MCHR1SLC2A1MEN1KMT2APDE3B | |
| Hydrochloric Acid SCHEMBL6594516 | 0.74 | SLC2A1 (0.49) | MCHR1SLC2A1MEN1KMT2APDE3B | |
| Hydrochloric Acid SCHEMBL6600313 | 0.73 | SLC2A1 (0.39) | MCHR1SLC2A1MEN1KMT2APDE3B | |
| SCHEMBL6620928 | 0.60 | SLC2A1 (0.50) | MCHR1SLC2A1SMN1; SMN2KDM4ETSHR | |
| SCHEMBL1537230 | 0.60 | FNTA (0.44) | MEN1KMT2ASMN1; SMN2LMNACYP1A2 | |
| SCHEMBL7978299 | 0.60 | MCHR1 (0.62) | MCHR1SLC2A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL7978307 | 0.60 | MCHR1 (0.62) | MCHR1SLC2A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL7978296 | 0.60 | MCHR1 (0.62) | MCHR1SLC2A1MEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063757-A1 | Urotensin-ll receptor antagonists | SMITHKLINEE BEECHAM CORPORATION | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063757-A1 | Urotensin-ll receptor antagonists | UTS2R, PLAUR, SCTR | MCHR1 499/4885SLC2A1 3284/4885MEN1 3428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.